OSUR | OraSure Technologies, Inc.

Index- P/E13.32 EPS (ttm)0.40 Insider Own0.70% Shs Outstand73.11M Perf Week-8.04%
Market Cap396.29M Forward P/E- EPS next Y-0.32 Insider Trans25.27% Shs Float69.78M Perf Month-25.39%
Income29.30M PEG0.67 EPS next Q-0.07 Inst Own87.90% Short Float / Ratio2.00% / 2.29 Perf Quarter-13.77%
Sales474.70M P/S0.83 EPS this Y22.60% Inst Trans-4.21% Short Interest1.40M Perf Half Y5.62%
Book/sh5.39 P/B0.98 EPS next Y-390.90% ROA6.60% Target Price6.94 Perf Year73.60%
Cash/sh1.49 P/C3.53 EPS next 5Y20.00% ROE8.10% 52W Range2.62 - 7.82 Perf YTD9.13%
Dividend- P/FCF- EPS past 5Y-20.00% ROI-6.70% 52W High-32.74% Beta0.10
Dividend %- Quick Ratio4.80 Sales past 5Y18.30% Gross Margin39.90% 52W Low100.76% ATR0.27
Employees840 Current Ratio6.20 Sales Q/Q129.00% Oper. Margin3.70% RSI (14)40.45 Volatility3.27% 5.57%
OptionableYes Debt/Eq0.00 EPS Q/Q233.20% Profit Margin6.20% Rel Volume1.06 Prev Close5.41
ShortableYes LT Debt/Eq0.00 EarningsMay 10 AMC Payout0.00% Avg Volume610.48K Price5.26
Recom2.70 SMA20-3.45% SMA50-15.47% SMA2000.83% Volume647,482 Change-2.77%
Date Action Analyst Rating Change Price Target Change
Jan-03-23Resumed Evercore ISI In-line $5
Sep-22-21Downgrade Raymond James Outperform → Mkt Perform
Aug-21-20Initiated Evercore ISI Outperform $22
Aug-10-20Initiated JP Morgan Neutral $18
Aug-10-20Initiated Citigroup Buy $18
Aug-07-20Upgrade Raymond James Mkt Perform → Outperform $16
Jun-25-20Initiated Lake Street Buy $19
Apr-21-20Resumed Stephens Equal-Weight $14
Oct-23-18Resumed Raymond James Mkt Perform
Jul-16-18Downgrade Stephens Overweight → Equal-Weight
Jun-08-23 11:03AM
Jun-01-23 06:29AM
May-16-23 06:08AM
May-12-23 07:12AM
May-11-23 11:03AM
05:35PM Loading…
May-10-23 05:35PM
May-03-23 07:05AM
Apr-26-23 08:00PM
Apr-21-23 09:40AM
Apr-05-23 08:38AM
Mar-29-23 07:30AM
Mar-21-23 07:22AM
Mar-20-23 07:20AM
11:53AM Loading…
Mar-08-23 11:53AM
Feb-23-23 12:20PM
Feb-16-23 04:38PM
Feb-15-23 03:48PM
Feb-14-23 06:05PM
Feb-07-23 07:05AM
Dec-21-22 07:52AM
Dec-01-22 07:05AM
Nov-14-22 07:05AM
Nov-08-22 06:05PM
Nov-03-22 09:15AM
07:05AM Loading…
Nov-02-22 07:05AM
Nov-01-22 07:05AM
Oct-07-22 09:14AM
Oct-01-22 10:30AM
Sep-28-22 10:28AM
Sep-20-22 04:05PM
Sep-14-22 07:05AM
Aug-31-22 06:29AM
Aug-14-22 08:28AM
Aug-09-22 07:25PM
Aug-02-22 07:05AM
Jul-28-22 07:05AM
Jul-14-22 08:42AM
Jun-14-22 08:31AM
Jun-08-22 04:05PM
May-25-22 07:05AM
May-23-22 04:05PM
May-17-22 07:05AM
May-10-22 06:55PM
May-04-22 06:45PM
May-03-22 04:05PM
Apr-24-22 10:21AM
Apr-07-22 07:05AM
Mar-31-22 07:05AM
Mar-22-22 04:05PM
Feb-23-22 04:05PM
Feb-16-22 04:05PM
Jan-31-22 07:54AM
Jan-25-22 07:05AM
Jan-24-22 10:04AM
Jan-19-22 05:38PM
Jan-13-22 04:05PM
Jan-06-22 11:09AM
Jan-05-22 04:24PM
Dec-14-21 07:05AM
Nov-30-21 07:05AM
Nov-19-21 07:05AM
Nov-11-21 09:34AM
Nov-09-21 07:05AM
Nov-08-21 07:05AM
Nov-04-21 12:31AM
Nov-03-21 07:15PM
Nov-02-21 12:25PM
Oct-27-21 03:03PM
Oct-04-21 03:39PM
Sep-23-21 10:00AM
Sep-20-21 06:00AM
Sep-10-21 11:14AM
Sep-02-21 07:00AM
Aug-03-21 11:01PM
Jul-28-21 03:04PM
Jul-27-21 04:01PM
Jul-12-21 07:28AM
Jun-17-21 04:05PM
Jun-14-21 06:00AM
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's diagnostic products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgeneGUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McGrath Kenneth JChief Financial OfficerMay 30Buy4.93100,000492,810285,512May 31 04:14 PM
LANCASTER RONNY BDirectorAug 26Buy4.0050,000200,000104,782Aug 29 05:08 PM
Aspinall Mara G.DirectorAug 25Buy4.196,00025,13877,218Aug 31 08:42 AM
Gagliano Nancy JDirectorAug 17Buy4.392,2009,65842,160Aug 22 06:54 PM
Celano MichaelDirectorAug 12Buy4.4912,00053,916111,823Aug 16 04:01 PM